BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.55	0.88	1.71	21.03	3.06
Short-Term Investments	10.18	10.18	13.04	-	-
Cash & Short-Term Investments	10.73	11.07	14.75	21.03	3.06
Cash Growth	-3.01%	-24.97%	-29.85%	586.11%	184071.27%
Receivables	0.19	0.02	0.02	0.01	0.02
Prepaid Expenses	0.22	0.31	0.36	0.44	0.11
Total Current Assets	11.14	11.39	15.13	21.47	3.19
Property, Plant & Equipment	0.36	0.51	0.5	0.4	0.5
Other Intangible Assets	0.62	0.71	0.8	0.59	0.66
Long-Term Deferred Charges	0.15	-	-	-	-
Total Assets	12.28	12.61	16.43	22.45	4.35
Accounts Payable	0.48	0.19	0.17	0.05	0.12
Accrued Expenses	0.74	0.71	0.13	0.13	0.11
Current Portion of Long-Term Debt	-	-	-	0.06	-
Current Portion of Leases	-	0.16	0.14	0.12	0.16
Other Current Liabilities	2.52	1.54	5.54	-	0.66
Total Current Liabilities	3.75	2.61	5.98	0.36	1.04
Long-Term Debt	-	-	-	0.19	4.27
Long-Term Leases	-	-	0.16	0.3	0.36
Total Liabilities	3.75	2.61	6.14	0.86	5.68
Common Stock	0	0	0	0	0
Additional Paid-In Capital	164.2	156.69	146.56	155.73	88.51
Retained Earnings	-155.68	-146.7	-136.28	-134.15	-89.84
Total Common Equity	8.52	9.99	10.28	21.58	-1.33
Shareholders' Equity	8.53	10	10.29	21.6	-1.33
Total Liabilities & Equity	12.28	12.61	16.43	22.45	4.35
Total Debt	-	0.16	0.3	0.67	4.79
Net Cash (Debt)	10.73	10.9	14.45	20.36	-1.73
Net Cash Growth	-1.57%	-24.53%	-29.03%	-	-
Net Cash Per Share	1.38	2.58	3.99	17.14	-4.38
Filing Date Shares Outstanding	6.92	6.77	3.77	3.63	0.79
Total Common Shares Outstanding	6.92	4.71	3.68	3.52	0.72
Working Capital	7.4	8.78	9.15	21.1	2.14
Book Value Per Share	1.23	2.12	2.79	6.13	-1.86
Tangible Book Value	7.89	9.28	9.47	20.99	-2
Tangible Book Value Per Share	1.14	1.97	2.58	5.96	-2.79
Machinery	-	0.89	0.74	0.52	0.49
Leasehold Improvements	-	0.34	0.34	0.3	0.3

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q